Literature DB >> 30686693

Platelet-rich fibrin as an alternative adjunct to tendon-exposed wound healing: A randomized controlled clinical trial.

Shuang Zhang1, DongSheng Cao2, Juan Xie1, HongHong Li1, ZengHong Chen1, Qiong Bao1.   

Abstract

BACKGROUND: The use of platelet-rich fibrin (PRF) has attracted great interest in the treatment of oral and maxillofacial procedures, gingival recessions, and bone healing. However, PRF has been reported hardly to prepare wound bed before skin grafting. This randomized clinical study sought to identify the effect of PRF as an alternative adjunct to tendon-exposed wound healing.
METHODS: Thirty-six patients with tendon-exposed wounds were treated by applying Integra or PRF (n=18 per group). The take rate of Integra or PRF and pain levels assessed with the four-point verbal rating scale (VRS-4) for the first 5days after application were measured for each condition. Data of texture change analysis were assessed and recorded for a duration of 3 months postoperatively.
RESULTS: The take rate was less in the Integra group than in the PRF group (92.39 vs 97.83 P<0.001). After surgery, compared to the Integra group, the patients in the PRF group reported significantly lower pain scores (P<0.001). Texture changes from the Integra group were rated higher than those from the PRF (P<0.001).
CONCLUSION: The use of PRF could be an option for tendon exposed areas where the wound is unfit for standard skin grafting or flap transfer.
Copyright © 2019 Elsevier Ltd and ISBI. All rights reserved.

Entities:  

Keywords:  Integra; Pain; Platelet-rich fibrin; Take rate; Texture change

Mesh:

Substances:

Year:  2019        PMID: 30686693     DOI: 10.1016/j.burns.2019.01.007

Source DB:  PubMed          Journal:  Burns        ISSN: 0305-4179            Impact factor:   2.744


  3 in total

1.  The impact of gender and peripheral blood parameters on the characteristics of L-PRF membranes.

Authors:  Catherine Andrade Aldana; Felipe Ugarte Amenabar; Carolina Inostroza Silva; Paulo Diaz Calderon; David Rosenberg Messina; Nelson Pinto Carrasco; Marc Quirynen
Journal:  J Oral Biol Craniofac Res       Date:  2022-09-01

2.  Evolution of a concept with enzymatic debridement and autologous in situ cell and platelet-rich fibrin therapy (BroKerF).

Authors:  Matthias Waldner; Tarek Ismail; Alexander Lunger; Holger J Klein; Riccardo Schweizer; Oramary Alan; Tabea Breckwoldt; Pietro Giovanoli; Jan A Plock
Journal:  Scars Burn Heal       Date:  2022-01-06

Review 3.  Evaluation of Platelet-Rich Plasma Therapy for Peripheral Nerve Regeneration: A Critical Review of Literature.

Authors:  Sulong Wang; Xilin Liu; Yueshu Wang
Journal:  Front Bioeng Biotechnol       Date:  2022-03-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.